Atlas Trials

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Clinical trial NCT00083382 · COMPLETED

Trial details

NCT number
NCT00083382
Sponsor
University of Arkansas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
1998-12-01
Primary completion
2014-05-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.